Director exercised or converted 8,700 COLL derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 8, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 10, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001276038-26-000006
Added to OQROOct 6, 2026, 10:35 PM UTC Data qualityVerified: identifiers matched exactly IssuerCOLLEGIUM PHARMACEUTICAL, INC Reporting personGino Santini SecurityStock Option (Right to Purchase) TableDerivative (Table II) Transaction dateJun 8, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- The option is fully vested and exercisable.
Around the same time
Derivative exercise or conversion — not an open-market buy.
A board member of Collegium Pharmaceutical sold $681 of Collegium Pharmaceutical shares. Nobody planned it ahead of time.
Compensation award — excluded from discretionary-purchase analysis.